Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma (2011)
- Authors:
- USP affiliated authors: DAMANTE, JOSE HUMBERTO - FOB ; GARLET, GUSTAVO POMPERMAIER - FOB ; SILVA, JOÃO SANTANA DA - FMRP ; CAMPANELLI, ANA PAULA - FOB
- Unidades: FOB; FMRP
- DOI: 10.1007/s00262-011-1007-5
- Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS (IMUNOLOGIA); NEOPLASIAS BUCAIS (IMUNOLOGIA); LÁBIO; INFLAMAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Immunology Immunotherapy
- ISSN: 0340-7004
- Volume/Número/Paginação/Ano: v. 60, n. 7, p. 965-974, July 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MALASPINA , Tatiana Salles de Souza et al. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunology Immunotherapy, v. 60, n. 7, p. 965-974, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00262-011-1007-5. Acesso em: 21 jan. 2026. -
APA
Malaspina , T. S. de S., Gasparoto, T. H., Costa, M. R. S. N., Melo Jr, E. J. F. de, Ikoma, M. R. V., Damante, J. H., et al. (2011). Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunology Immunotherapy, 60( 7), 965-974. doi:10.1007/s00262-011-1007-5 -
NLM
Malaspina TS de S, Gasparoto TH, Costa MRSN, Melo Jr EJF de, Ikoma MRV, Damante JH, Cavassani KA, Garlet GP, Silva JS da, Campanelli AP. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma [Internet]. Cancer Immunology Immunotherapy. 2011 ; 60( 7): 965-974.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1007/s00262-011-1007-5 -
Vancouver
Malaspina TS de S, Gasparoto TH, Costa MRSN, Melo Jr EJF de, Ikoma MRV, Damante JH, Cavassani KA, Garlet GP, Silva JS da, Campanelli AP. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma [Internet]. Cancer Immunology Immunotherapy. 2011 ; 60( 7): 965-974.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1007/s00262-011-1007-5 - Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment
- Regulatory T cells in the actinic cheilitis
- CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses
- Elastase and cytokines in actinic cheilitis and oral squamous cell carcinoma
- Patients with Lepromatous Leprosy are characterized by increased frequency of suppressive regulatory T cells in the blood and lesions
- Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression
- Inflammatory mediators in murine squamous cell carcinoma
- CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction
- Budlein a influences neutrophils activation
- CCR5+ cells modulate RANKL+ cell migration, inflammatory reaction development and experimental periodontitis outcome in mice
Informações sobre o DOI: 10.1007/s00262-011-1007-5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
